Showing 34,879 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

Types of HIV tests

Reuters–along with many other news sites–parrots erroneous news release on HIV testing via USB stick

Editor's pick
Health News Review
15 November 2016
Self-testing & home testing

bioLytical Launches World's Fastest HIV Self Test in UK

Editor's pick
bioLytical press release
15 November 2016
Epidemiology & behaviour

Long term decline in consistent condom use among Australian gay men

News
15 November 2016
Hepatitis C treatment

Grazoprevir/elbasvir + sofosbuvir highly effective for hard-to-treat genotype 3 hepatitis C patients

News
14 November 2016
Condoms & lubricant

Californians Reject Condoms in Porn Ballot Measure Proposition 60

Editor's pick
The Wrap
14 November 2016
Access to healthcare

Where hepatitis C rates are seven times the US average — and a cure is kept out of reach

Editor's pick
STAT
14 November 2016
Government, leadership & policy

In a Trump Presidency, Portents of Stigma and Sickness for People Living With HIV

Editor's pick
The Body
14 November 2016
Hepatitis C treatment

Liver cancer risk reduced after hepatitis C treatment, but vigilance needed for aggressive cancers in months after treatment

News
14 November 2016
Hepatitis C treatment

Real-world responses to HCV treatment among US veterans match best clinical trial results

News
14 November 2016
Health monitoring in resource-limited settings

HIV test performed on USB stick

Editor's pick
Imperial College
11 November 2016
Hepatitis B

U.S. Food and Drug Administration Approves Gilead’s Vemlidy® (Tenofovir Alafenamide) for the Treatment of Chronic Hepatitis B Virus Infection

Editor's pick
Gilead press release
11 November 2016
PrEP

The 13 NHS treatments at risk... because taxpayers face paying for controversial HIV drug

Editor's pick
Daily Mail
11 November 2016
PrEP science

The ‘long tail’ problem: injected-PrEP trial will be extended due to persistence of drug in companion study

News
11 November 2016
Government, leadership & policy

What the HIV/AIDS Community Is Saying About the 2016 Election Results

Editor's pick
Poz
10 November 2016
PrEP policies & guidelines

NHS England loses appeal – it must consider providing PrEP

News
10 November 2016
PrEP

NHS England has power to fund Prep HIV drug, court decides

Editor's pick
BBC
10 November 2016
PrEP

Update on PrEP

Editor's pick
NHS England
10 November 2016
PrEP

Court Of Appeal: NHS Can Provide The HIV Prevention Drug

Editor's pick
BuzzFeed
10 November 2016
PrEP

Final PrEP HIV drug case win for National AIDS Trust at Court of Appeal

Editor's pick
NAT
10 November 2016
The search for an HIV prevention vaccine

J&J vaccine plus Gilead immune booster shows promise as HIV fighter

Editor's pick
Reuters
10 November 2016
Telling people you have HIV

Grindr, Largest Gay Hookup App, Adds Fields for HIV Status, Undetectable, and PrEP Use

Editor's pick
The Body
10 November 2016
Government, leadership & policy

Waking Up In a Country Where the President-Elect Has No HIV Strategy

Editor's pick
The Body
10 November 2016
Changing treatment

Tenofovir alafenamide works well and improves kidney and bone markers in older people living with HIV

News
10 November 2016
Harm reduction

Reaching out with naloxone

Editor's pick
Drink & Drug News
9 November 2016